Sign in

CIK 0000875045 · Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330112644
Phone
6176792000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Shares withheld for taxes Head of Research gave up 345 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Accounting Officer gave up 8 shares (to pay taxes)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Planned sale Director sold 1,186 shares at an average $202.15 ($239,750)
  6. 4 Grant or award Director acquired 1,505 shares (grant or award)
  7. 4 Grant or award Director acquired 1,505 shares (grant or award)
  8. 4 Grant or award Director acquired 1,505 shares (grant or award)
  9. 4 Grant or award Director acquired 1,505 shares (grant or award)
  10. 4 Grant or award Director acquired 1,505 shares (grant or award)
  11. 4 Grant or award Director acquired 1,505 shares (grant or award)
  12. 4 Grant or award Director acquired 1,505 shares (grant or award)
  13. 4 Grant or award Director acquired 1,505 shares (grant or award)
  14. 4 Grant or award Director acquired 2,005 shares (grant or award)
  15. 4 Shares withheld for taxes Head of Corporate Development gave up 455 shares (to pay taxes)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Shares withheld for taxes Chief Accounting Officer gave up 54 shares (to pay taxes)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy Head of Pharm Ops and Tech bought 3 shares at $195.04 ($585)

Page 1 of 86 · 1,714 filings